FIBROGEN

We work at the intersection of groundbreaking science and patient need. Our research and development teams seek to identify and develop innovative drugs with the greatest promise of becoming first-in-class medicines for the treatment of chronic and life-threatening conditions such as anemia, idiopathic pulmonary fibrosis (IPF), Duchenne muscular dystrophy (DMD), and locally advanced pancreatic cancer (LAPC). Our product candidates leverage the body's natural pathways, providing us with the scientific insight to investigate their potential across multiple diseases... We are dedicated to responsibly developing groundbreaking therapies for serious and life-threatening diseases.

Also known as: FibroGen China, FibroGen, Inc.

Primary location: San Francisco United States